Related Experiment Video

Updated: May 25, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Role of ABC transporters in cancer chemotherapy

Yue-Li Sun1, Atish Patel, Priyank Kumar

  • 1Department of Pharmaceutical Sciences, St. John's University, Jamaica, NY 11439, USA.

Chinese Journal of Cancer
|January 20, 2012
PubMed

Insights

Multidrug resistance (MDR) in cancer, driven by ATP-binding cassette (ABC) transporters, reduces chemotherapy effectiveness. Strategies targeting ABC transporters aim to improve cancer treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Multidrug resistance (MDR) in cancer cells significantly impairs chemotherapy efficacy, leading to increased mortality.
  • Overexpression of ATP-binding cassette (ABC) transporters is a primary mechanism conferring MDR by actively exporting drugs from cancer cells.
  • Reduced intracellular drug concentration due to ABC transporter activity limits the effectiveness of chemotherapeutic agents.

Discussion:

  • ATP-binding cassette (ABC) transporters play a critical role in the development of multidrug resistance in various cancers.
  • Understanding the function and regulation of ABC transporters is crucial for developing novel therapeutic strategies.
  • Modulators targeting ABC transporters offer a promising approach to resensitize resistant cancer cells to chemotherapy.

Key Insights:

  • The overexpression of ATP-binding cassette (ABC) transporters is a major cause of multidrug resistance in cancer.
  • Inhibiting or modulating ABC transporter activity can restore cancer cell sensitivity to chemotherapy drugs.
  • Targeting ABC transporters presents a viable strategy to enhance the efficacy of existing anticancer treatments.

Outlook:

  • Further research into specific ABC transporter inhibitors is needed to optimize combination therapies.
  • Developing novel strategies to overcome MDR will improve patient survival rates in oncology.
  • Personalized medicine approaches may involve assessing ABC transporter expression to guide treatment selection.

More Related Videos

Screening Ion Channels in Cancer Cells06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...